Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: LY2140023.For Schizophrenia.

Posted by jrbecker76 on August 19, 2014, at 11:16:01

In reply to Re: LY2140023.For Schizophrenia., posted by Lamdage22 on August 15, 2014, at 13:57:04

> Again, check out "see also"

Unfortunately, this drug (aka Pomaglumetad methionil) failed to find significant findings in Ph III trials and is more than likely abandoned. There actually was some interesting data from the trial that showed that a subgroup of patients with a particular genotypic biomarker for the 5-HT2a receptor did particularly well with it. But I'm not sure Lilly is still pursuing it. They might still be looking at this class for Bipolar d/o though.




Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker76 thread:1069838